Rodman & Renshaw Starts Alnylam Pharmaceuticals (ALNY) at Market Outperform
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $147.08 -0.42%
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 51
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 51
Join SI Premium – FREE
Rodman & Renshaw initiates coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY) with a Market Outperform. PT $12.00.
For more ratings news on Alnylam Pharmaceuticals click here and for the rating history of Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $7.13 yesterday.
For more ratings news on Alnylam Pharmaceuticals click here and for the rating history of Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $7.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Okeanis Eco Tankers Corp (ECO) at Buy, 'solid competitive advantage'
- Evercore ISI Starts Nova Measuring Instruments (NVMI) at Outperform, 'Gate-All-Around + Advanced Packaging Play'
- LuxUrban Hotels Inc. (LUXH) PT Lowered to $4 at Jones Trading
Create E-mail Alert Related Categories
New CoverageRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
